Atlas Trials

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Clinical trial NCT01849146 · COMPLETED

Trial details

NCT number
NCT01849146
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
GlioblastomaRecurrent Glioblastoma
Start date
2013-10-24
Primary completion
2021-07-29
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.